Top Markets
Coin of the day
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
Rang in Aktien #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
Aktienkurs
$0.94
Zuletzt synchronisiert: 2025-02-28
Marktkapitalisierung
$2.73M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Fresh Tracks Therapeutics, Inc. (FRTX)

Kategorie

Gewinn für Fresh Tracks Therapeutics, Inc. (FRTX)
Gewinn im Dec 2023 TTM: $-5.89M
Laut den aktuellen Finanzberichten von Fresh Tracks Therapeutics, Inc. betragen die aktuellen Gewinne des Unternehmens $-5.89M. Im Jahr 2022 erzielte das Unternehmen einen Gewinn von $-21.10M, eine Steigerung gegenüber dem Gewinn im Jahr 2021, der $-39.47M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Fresh Tracks Therapeutics, Inc. von 2000 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $-5.89M 3.46%
2023 $-5.69M -73.02%
2022 $-21.10M -46.54%
2021 $-39.47M 88.75%
2020 $-20.91M -12.41%
2019 $-23.88M 46.90%
2018 $-16.25M 25.42%
2017 $-12.96M 44.43%
2016 $-8.97M -2.87%
2015 $-9.24M -43.98%
2014 $-16.49M -47.21%
2013 $-31.24M 36.42%
2012 $-22.90M 214.42%
2011 $-7.28M -76.03%
2010 $-30.39M 6.40%
2009 $-28.56M -22.56%
2008 $-36.88M 3.01%
2007 $-35.80M 56.49%
2006 $-22.88M 0.00%
2005 0.00 0.00%
2004 0.00 -100.00%
2003 $-26.59M -25.80%
2002 $-35.83M 0.00%
2001 0.00 0.00%
2000 0.00 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$5.27B -89,641.67%
US
$1.95B -33,212.38%
NL
- -
CH
- -
KR
$3.01B -51,122.19%
BE